What pd 1 receptor does pembrolizumab inhibit?

Pembrolizumab targets and inhibits the PD-1 receptor on T cells (CD279). It binds PD-1 and blocks its interaction with the ligands PD-L1 and PD-L2, lifting the inhibitory PD-1 pathway to re-activate T-cell anti-tumor activity.